Auranofin Capsule
Product Images NDC 85437-093

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Auranofin (NDC 85437-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coral Way Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label3)

The image shows a packaging label for Auranofin capsules, 3 mg strength, manufactured by Coral Way Pharma, LLC. The label indicates it contains 60 capsules, is for prescription use only (RX only), and includes storage instructions (store between 15°-30°C). Dosage instructions and safety warnings are also present, along with the NDC 85437-093-06 and a barcode.*

FDA Label Image

Chemical Structure (Rid01 0003 01)

Chemical structure diagram of the active ingredient auranofin. The diagram shows molecular components including gold (Au) and phosphorus atoms connected to organic functional groups, representing the compound's chemical configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.